Skip to content

DG Gel 8 A/B/D 210384Recalls & reported problems

Diagnostic Grifols SA · The DG Gel 8 A/B/D card is for the determination of human A, B and D antigens on the surface of red blood cells of two separate blood samples. For use with the DG Gel System. For in vitro diagnostic use.

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08437014205930), received between Sep 29, 2025 and Sep 29, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “False Positive Result” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • False Positive Result1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 29, 2025False Positive Result; False Positive Result

    THE CUSTOMER REPORTED RH DISCREPANCIES IN TWO DIFFERENT PATIENT SAMPLES: SAMPLE (B)(6) (FEMALE PATIENT) TESTED ON (B)(6) 2025 USING DG GEL 8 A/B/D (LOT 25007.01), DG GEL 8 NEUTRAL (LOT 25003.1.1), AND REVERSE-CYTE A1, B (LOT 641425033). RESULT: RH POSITIVE (3+) PATIENT HISTORY: A NEGATIVE, NO TRANSFUSIONS, PREGNANT, RECEIVED RHOGAM ON (B)(6) 2025. SAMPLE (B)(6) (MALE PATIENT) TESTED ON (B)(6) 2025 WITH THE SAME REAGENTS AND LOTS AS THE OTHER SAMPLE, DG GEL 8 A/B/D (LOT 25007.01), DG GEL 8 NEUTRAL (LOT 25003.01), AND REVERSE-CYTE A1, B (LOT 641425033). RESULT: RH POSITIVE (2+) PATIENT HISTORY: O NEGATIVE, RECEIVED TWO UNITS OF O NEGATIVE BLOOD IN (B)(6) 2024. ON (B)(6) 2025, BOTH SAMPLES WERE RETESTED USING DG GEL 8 A/B/D (LOT 25009.01), AND BOTH SHOWED RH POSITIVE (3+) IN THE MICROTUBE D. ON (B)(6) 2025, THE SAMPLES WERE THEN TESTED USING THE DG GEL 8 ABO/RH (2D) CARD (LOT 25003.01), AND THE RESULTS OBTAINED FOR BOTH SAMPLES WERE ALSO POSITIVE (3+) IN THE TWO D WELLS. THIS CARD HAS THE SAME D CLONE AS THE DG GEL 8 A/B/D. FINALLY, BOTH SAMPLES WERE RETESTED USING TUBE TECHNIQUE WITH GRIFOLS ANTI-D REAGENT (LOT 029000), YIELDING NEGATIVE RESULTS (AS EXPECTED).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23165981 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page